You can buy or sell PhaseBio and other stocks, options, ETFs, and crypto commission-free!
PhaseBio Pharmaceuticals, Inc. Common Stock, also called PhaseBio, is engaged in the development and commercialization of biotherapeutics for the treatment of orphan diseases. Read More It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
52 Week High
52 Week Low
-$0.37 per share
Available Nov 14, Pre-Market